NCT03856879

Brief Summary

This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 27, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

May 21, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

July 30, 2025

Status Verified

June 1, 2025

Enrollment Period

6 years

First QC Date

February 20, 2019

Last Update Submit

July 25, 2025

Conditions

Keywords

Chronic obstructive pulmonary diseaseintervention studiesrandomized controlled trialprovider satisfactionpatient satisfactionE-consult

Outcome Measures

Primary Outcomes (1)

  • % of COPD care recommendations received by patients of enrolled providers

    % of COPD care recommendations received by the patient, examined collectively for each patient and individually by type of recommendation (e.g. use of spirometry, long acting bronchodilator, smoking cessation, vaccination, etc.) to assess the overall quality of COPD care.

    6 months following provider/patient appointment

Secondary Outcomes (1)

  • Patient health-related quality of life

    6 weeks following provider/patient appointment

Other Outcomes (1)

  • HIV provider satisfaction with specialty-care support

    Baseline: prior to intervention roll-out. Follow-up: after exposure to intervention (defined as having received at least 2 E-consults), up to 3 years.

Study Arms (2)

Usual care

NO INTERVENTION

Providers in this arm will provide usual care to their HIV+ patients with COPD.

Proactive E-consult

EXPERIMENTAL

Providers in this arm will receive proactive E-consults with expert recommendations for COPD care prior to appointments with HIV+ patients with COPD.

Behavioral: Proactive E-consult

Interventions

E-consult recommendations and orders will be developed by a panel of pulmonologists and will address a range of care elements for patients with COPD.

Proactive E-consult

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Providers:
  • Outpatient infectious disease providers at one of the seven local sites participating in this study.
  • Patients:
  • HIV+ patients with COPD treated by providers enrolled in the study.

You may not qualify if:

  • Providers:
  • Trainees
  • Patients:
  • Significant cognitive dysfunction, language barriers or severe psychiatric disorder, impairing ability to participate in surveys and interviews.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

VA Greater Los Angeles Healthcare System

Los Angeles, California, 90073, United States

Location

VA Eastern Colorado Health Care System

Denver, Colorado, 80012, United States

Location

VA Connecticut Healthcare System

New Haven, Connecticut, 06111, United States

Location

Washington DC VA Medical Center

Washington D.C., District of Columbia, 20422, United States

Location

Atlanta VA Health Care System

Atlanta, Georgia, 30033, United States

Location

Philadelphia VA Medical Center

Philadelphia, Pennsylvania, 19104, United States

Location

Nashville VA Medical Center

Nashville, Tennessee, 37212, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAcquired Immunodeficiency SyndromePatient Satisfaction

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • David H. Au, MD, MS

    VA Puget Sound Health Care System

    PRINCIPAL INVESTIGATOR
  • Kristina A. Crothers, MD

    VA Puget Sound Health Care System

    PRINCIPAL INVESTIGATOR
  • Christian D. Helfrich, PhD, MPH

    VA Puget Sound Health Care System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study staff conducting patient surveys and evaluating quality of COPD care will be blinded to intervention/control assignment of the patient's provider.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Providers will be randomly assigned to the intervention or control group, stratified by site, provider type and panel size.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 27, 2019

Study Start

May 21, 2019

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

July 30, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations